On November 29, the 8th Cell Bioindustry Conference and the 6th China Biomedical Innovation Cooperation Conference and Chengdu Biomedical Innovation Achievements Roadshow jointly sponsored by Chengdu High-tech Medical Association and Guangzhou Zhenghe Exhibition Service Co., Ltd. were completed in Chengdu!

More than 20 online and offline investment institutions participated in the meeting, 5 benchmark enterprises in the biomedical industry participated in the meeting on the spot, and 191,000 people watched it online to share the latest information on the development of the industry.

Opening speech

At the beginning of the meeting, Yin Hui, a second-level researcher of the Science, Education and Health Service Department of the Chengdu Health Commission, delivered an enthusiastic speech. She briefly analyzed the development trend of Chengdu's health industry and expressed deep concern and concern for the development of the health industry. She looked forward to the in-depth exchanges and investment cooperation through the meeting to promote the further optimization of the ecology of the regional medical and health industry and promote the high-quality development of the health industry.

Yin Hui, second-level researcher of the Science, Education and Health Service Department of Chengdu Health Commission

Statement by the representative of the investor

Yu Jing, a partner of Mifang Health Fund, talked about her views on the field of pharmaceutical innovation in the primary market, and gave suggestions on how to seize opportunities in the current pharmaceutical market challenges.

Yu Jing, Partner of Mifang Health Fund

Wang Zhen, a partner of Mingfeng Capital, made a brief prediction of the investment trend in the field of innovative pharmaceutical science and technology. By establishing an economic model and analyzing the inflection point of the industry, he gave the audience an answer to where technology in the field of medicine is more likely to obtain capital favor.

Wang Zhen, Partner of Mingfeng Capital

Theme sharing

The meeting invited representatives of five health industry fields, including Changrui Biotechnology (Chengdu) Co., Ltd., Chongqing Meipulan Technology Co., Ltd., Chengdu Jieshide Technology Co., Ltd., Chengdu Huitai Biopharmaceutical Co., Ltd., Chengdu Xinrui Taikang Technology Co., Ltd., to share their innovative projects in their respective fields, demonstrating cutting-edge technologies in the fields of tumor-associlytic virus, NASH innovative treatment drugs, intelligent intravenous drug deployment solutions, new drugs for reversal pulmonary fibrosis, and CNS ion channel targeted new drugs, showing the huge market potential of achievement transformation with various data, breaking down technical barriers and taking the leading position.

Changrui Biotechnology (Chengdu) Co., Ltd. shares "New Adenovirus Carrier Onomalytic Virus"

Chongqing Meipulan Technology Co., Ltd. shares "NASH Innovative Therapeutic Drugs"

Chengdu Jist Technology Co., Ltd. shares "Intelligent Intravenous Drug Mixing Solution"

Chengdu Huitai Biomedicine Co., Ltd. shares "New Drugs for Reversing Pulmonary Fibrosis"

Chengdu Xinrui Taikang Technology Co., Ltd. shares "CNS Ion Channel Targeted New Drug"

After each project is shared, the meeting set up a questioning session, so that the investment representatives have a deeper understanding of technology, the project, and the enterprise. The response was warm and the atmosphere was lively. The two ends of investment and financing collide, deeply discuss investment and financing to promote project solutions, strengthen resource sharing, project cooperation and exchange, and jointly build a good high-tech health industry investment and financing ecological environment in Chengdu.

After the meeting, the participants expressed their congratulations on the successful success of the road show and thanked the Chengdu High-tech Medical Association Medical Industry Integration Collaborative Innovation Center for the capital supply and demand cooperation platform for science and technology innovation project enterprises and financial investment institutions, so that the two sides have the opportunity to exchange information and seek common development.

The smooth convening of this meeting will further strengthen the confidence and determination of Chengdu High-tech Medical Association to promote the driving medical innovation and the integration of medical workers, help the high-quality and coordinated development of the regional biomedical industry, do a good job in the whole industry chain services of high-tech and biomedical research and development, and accelerate the transformation process of scientific and technological achievements in the biomedical industry.